Summary
The reaction between activated factor X (Xa) and its natural inhibitor (XaI) was accelerated in vitro by both sodium heparin and an heparinoid, which was about 3 times less potent than heparin. The s. c. administration in humans of 5,000 units of sodium and calcium heparin was followed by the detection of a plasma activity potentiating XaI. In the majority of subjects, the heparinoid was not effective. These observations indicate that the use of heparinoids should not be considered as an alternative to heparin in the prevention of thromboembolism.
Similar content being viewed by others
References
P. Bianchini, V. Mantovani, E. Lo Marco andL. Bufalino, Arch. Pharmak.269, 470 (1971).
P. Bianchini, G. Guidi andB. Osima, Biochem. exp. Biol.10, 243 (1972).
I. Konttinen, Scand. J. clin. Lab. Invest.14, 87 (1962).
A. Gibelli, C. Parotti, E. Bolandrina, F. Nicrosini andP. de Nicola, Farmaco21, 596 (1966).
G. Prino andM. Mantovani, Eur. J. Pharmac.6, 190 (1969).
J. Aznar, M. Lasso andA. Fernandez, Nature, Lond.213, 1251 (1967).
J. F. Mustard andM. A. Packham, Pharmac. Rev.22, 97 (1970).
M. Mantovani, Arzneimittelforsch. (Drug Res.)23, 239 (1973).
C. C. Iliescu, L. Roma, V. Pastiu andI. Michel, Cor Vasa4, 225 (1962).
E. T. Yin andS. Wessler, Biochim. biophys. Acta201, 387 (1970).
E. T. Yin, S. Wessler andP. J. Stoll, J. biol. Chem.246, 3703 (1971).
S. Wessler andE. T. Yin, Circulation47, 671 (1973).
E. T. Yin, S. Wessler andJ. V. Butler, J. Lab. clin. Med.81, 298 (1973).
V. V. Kakkar, T. P. Corrigan andD. P. Fossard, Lancet2, 45 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mannucci, P.M., di Santo, C. & Franchi, F. Comparison of a natural heparinoid with sodium and calcium heparin for their effect on the inhibitor of activated factor X. Experientia 32, 1478–1480 (1976). https://doi.org/10.1007/BF01937446
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01937446